Literature DB >> 22718170

Prevalence and associated risk factors of ante-partum hemorrhage among Arab women in an economically fast growing society.

A Bener1, N M Saleh, M T Yousafzai.   

Abstract

OBJECTIVE: The aim of this study was to determine the prevalence and associated risk factors of antepartum hemorrhage (APH) in the third trimester of Arab women residing in Qatar and their neonatal outcome. DESIGN AND
SETTING: A prospective hospital-based study was conducted in the Women's Hospital and Maternity Clinics.
MATERIALS AND METHODS: The study was based on pregnant women in the third trimester from the first week of January 2010 to April 2011. A total of 2,056 pregnant women, who had any kind of maternal complications, were approached and 1,608 women (78.2%) expressed their consent to participate in the study. The questionnaire covered variables related to socio-demographic factors, family history, medical history, maternal complications and neonatal outcome. Multiple logistic regressions were used to describe the association between socio-demographic factors and APH.
RESULTS: The overall prevalence of APH among Arab women residing in Qatar was 15.3% with 6.7% among Qatari's and 8.6% among non-Qatari Arab women; the difference in ethnicities was not significant. Among maternal socio-demographic characteristics, lower education (primary or below AOR 1.72; 95%CI 1.22-2.43, and intermediate education AOR 1.41; 95%CI 0.88-2.26; P=0.005) compared to university education was significantly associated with APH. As for maternal biological characteristics, family history of G6PD (AOR 1.87; 95% CI 1.18-2.95; P=0.007) and family history of Down's Syndrome (AOR 1.88; 95%CI 1.35-2.62; P=<0.001) were significantly associated with APH at the multivariable level; family history of hypertension (OR 1.78; 95%CI 1.30-2.44; P<0.001) was significant at the univariate level. Neonatal outcomes as a result of APH included increased risk of Apgar score at 1 minutes <7 (AOR 1.44; 95%CI 1.12-2.02; P=0.04) and minor congenital anomaly (AOR 2.82; 95%CI 1.39-5.71; P=0.004).
CONCLUSION: Qatar has a high prevalence of APH. Poor education, family history of hypertension, G6PD and Down's syndrome were found to be significantly associated with increased risk of APH in Qatar. Neonates of APH are at significantly increased risk of adverse outcome. Thus it is essential that obstetricians are alerted to these risk factors for early detection and to decrease the negative effects of APH.

Entities:  

Mesh:

Year:  2012        PMID: 22718170     DOI: 10.4103/1119-3077.97315

Source DB:  PubMed          Journal:  Niger J Clin Pract            Impact factor:   0.968


  5 in total

1.  Adverse Neonatal Outcome are More Common among Babies Born by Cesarean Section than Naturally Born Babies at Public Hospitals in Eastern Ethiopia: A Comparative Prospective Follow-Up Study at Eastern Ethiopia.

Authors:  Maleda Tefera; Nega Assefa; Kedir Teji Roba; Letta Gedefa
Journal:  Glob Pediatr Health       Date:  2021-05-25

2.  Risk factors of placental abruption.

Authors:  Hooria Seyedhosseini Ghaheh; Awat Feizi; Maryam Mousavi; Davood Sohrabi; Leila Mesghari; Zahra Hosseini
Journal:  J Res Med Sci       Date:  2013-05       Impact factor: 1.852

3.  Antepartum Hemorrhage: A Retrospective Analysis from a Northern Nigerian Teaching Hospital.

Authors:  Idris Usman Takai; Badia Maje Sayyadi; Hadiza Shehu Galadanci
Journal:  Int J Appl Basic Med Res       Date:  2017 Apr-Jun

4.  Frequency, Risk Factors, and Adverse Fetomaternal Outcomes of Placenta Previa in Northern Tanzania.

Authors:  Elizabeth Eliet Senkoro; Amasha H Mwanamsangu; Fransisca Seraphin Chuwa; Sia Emmanuel Msuya; Oresta Peter Mnali; Benjamin G Brown; Michael Johnson Mahande
Journal:  J Pregnancy       Date:  2017-02-21

5.  Measuring burden of diseases in a rapidly developing economy: state of Qatar.

Authors:  Abdulbari Bener; Mahmoud A Zirie; Eun-Jung Kim; Rama Al Buz; Mouayyad Zaza; Mohammed Al-Nufal; Basma Basha; Edward W Hillhouse; Elio Riboli
Journal:  Glob J Health Sci       Date:  2012-12-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.